Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
Clinical trial NCT03619798 · UNKNOWN
Trial details
- NCT number
- NCT03619798
- Sponsor
- Silver Lake Research Corporation
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-08-03
- Primary completion
- 2018-08-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.